dbo:abstract
|
- Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases. It was founded by Cand.med. and Dr.philos. in protein and lipid research, Lars Høie. (en)
|
dbo:assets
| |
dbo:equity
| |
dbo:foundingDate
| |
dbo:foundingYear
| |
dbo:industry
| |
dbo:keyPerson
| |
dbo:location
| |
dbo:netIncome
| |
dbo:numberOfEmployees
|
- 18 (xsd:nonNegativeInteger)
|
dbo:operatingIncome
| |
dbo:product
| |
dbo:revenue
| |
dbo:thumbnail
| |
dbo:type
| |
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 8721 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:assets
| |
dbp:equity
| |
dbp:foundation
| |
dbp:homepage
| |
dbp:industry
| |
dbp:keyPeople
|
- Birger Sørensen , Dag Arne Wivelstad, Aslak Aslaksen, Per Bengtsson (en)
|
dbp:location
| |
dbp:logo
|
- Bionor Pharma logo.png (en)
|
dbp:name
| |
dbp:netIncome
| |
dbp:numEmployees
| |
dbp:operatingIncome
| |
dbp:products
| |
dbp:revenue
| |
dbp:type
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases. It was founded by Cand.med. and Dr.philos. in protein and lipid research, Lars Høie. (en)
|
rdfs:label
| |
owl:sameAs
| |
skos:closeMatch
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:homepage
| |
foaf:isPrimaryTopicOf
| |
foaf:name
| |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |